BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25755610)

  • 1. Role of surveillance in prevention of hepatocellular carcinoma.
    Panda D
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S43-9. PubMed ID: 25755610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
    Best J; Bechmann LP; Sowa JP; Sydor S; Dechêne A; Pflanz K; Bedreli S; Schotten C; Geier A; Berg T; Fischer J; Vogel A; Bantel H; Weinmann A; Schattenberg JM; Huber Y; Wege H; von Felden J; Schulze K; Bettinger D; Thimme R; Sinner F; Schütte K; Weiss KH; Toyoda H; Yasuda S; Kumada T; Berhane S; Wichert M; Heider D; Gerken G; Johnson P; Canbay A
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):728-735.e4. PubMed ID: 31712073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.
    Tohra S; Duseja A; Taneja S; Kalra N; Gorsi U; Behera A; Kaman L; Dahiya D; Sahu S; Sharma B; Singh V; Dhiman RK; Chawla Y
    J Clin Exp Hepatol; 2021; 11(6):682-690. PubMed ID: 34866847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients.
    Schotten C; Ostertag B; Sowa JP; Manka P; Bechmann LP; Hilgard G; Marquardt C; Wichert M; Toyoda H; Lange CM; Canbay A; Johnson P; Wedemeyer H; Best J
    Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
    Yang T; Wang N; Wang F; Liu H; Shen F; Lv G
    BMJ Open; 2023 Sep; 13(9):e076467. PubMed ID: 37723113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk.
    Frenette CT; Isaacson AJ; Bargellini I; Saab S; Singal AG
    Mayo Clin Proc Innov Qual Outcomes; 2019 Sep; 3(3):302-310. PubMed ID: 31485568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and surveillance of hepatocellular carcinoma.
    Kim DY; Han KH
    Liver Cancer; 2012 Jun; 1(1):2-14. PubMed ID: 24159567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
    Lok AS; Sterling RK; Everhart JE; Wright EC; Hoefs JC; Di Bisceglie AM; Morgan TR; Kim HY; Lee WM; Bonkovsky HL; Dienstag JL;
    Gastroenterology; 2010 Feb; 138(2):493-502. PubMed ID: 19852963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
    Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
    Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
    Tokushige K; Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Shiratori K
    J Gastroenterol; 2010 Sep; 45(9):960-7. PubMed ID: 20376504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
    Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.
    Kumar A; Acharya SK; Singh SP; Saraswat VA; Arora A; Duseja A; Goenka MK; Jain D; Kar P; Kumar M; Kumaran V; Mohandas KM; Panda D; Paul SB; Ramachandran J; Ramesh H; Rao PN; Shah SR; Sharma H; Thandassery RB;
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S3-S26. PubMed ID: 25755608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.
    Hayashi M; Yamada S; Takano N; Okamura Y; Takami H; Inokawa Y; Sonohara F; Tanaka N; Shimizu D; Hattori N; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    In Vivo; 2021; 35(3):1749-1760. PubMed ID: 33910859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of alpha-fetoprotein,
    Song T; Wang L; Su B; Zeng W; Jiang T; Zhang T; Sun G; Wu H
    J Int Med Res; 2020 Mar; 48(3):300060519889270. PubMed ID: 31852373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA; Feng Z; Wang Y; Nguyen MH; Befeler AS; Roberts LR; Reddy KR; Harnois D; Llovet JM; Normolle D; Dalhgren J; Chia D; Lok AS; Wagner PD; Srivastava S; Schwartz M
    Gastroenterology; 2009 Jul; 137(1):110-8. PubMed ID: 19362088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.